Molecular Testing in Metastatic Gastric/GEJ Cancer

3 Visualizzazioni
administrator
administrator
06/30/23

David Ilson, MD, PhD, reflects on the role of molecular testing in the treatment of metastatic gastric/gastroesophageal junction cancer and its impact on prognosis and clinical decision making.

  • Categoria

Mostra di piรน

0 Commenti Ordina per

Nessun commento trovato

Commenti su Facebook

Avanti il prossimo